drugset / Trial / NCT04491643
Megestrol Acetate Plus Rosuvastatin in Young Women With Early Endometrial Carcinoma
NaSingle-groupOpen-labelTreatment
Summary
To explore the treatment efficacy of megestrol acetate plus rosuvastatin in patients with early endometrial carcinoma (EEC) seeking for conservative treatment.
Timeline
- Start
- 2020-09-01
- Primary completion
- 2023-08-11
- Completion
- 2025-04-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Megestrol Acetate | Other / unclassified | 160 mg | Oral |
| Subject | Rosuvastatin | Small molecule | 10 mg | Oral |